Skip to main content
lexblog.com/lib/WXV8K17Kviewrecordjson
LEX-WK-WXV8K17Kcrawled 2026-04-06 08:45Z

Ninth Circuit Ruling in FCA Case Predicated on 340B Pricing Violations Has Significant Implications for Pharma Manufacturers 

Craig B. Bleifer · Michael J. Podberesky · Jessica L. Vaughn, Ph.D. · Subject to Inquiry · Published April 6, 2026

Work details

firm or organization
McGuireWoods LLP
published
2026-04-06

Citation

Craig B. Bleifer, Michael J. Podberesky, Jessica L. Vaughn, Ph.D., Ninth Circuit Ruling in FCA Case Predicated on 340B Pricing Violations Has Significant Implications for Pharma Manufacturers , Subject to Inquiry (April 6, 2026) [The Library at LexBlog, LEX-WK-WXV8K17K, lexpid.org/WXV8K17K]